• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Gastrointestinal
  • Drug Interaction Study Between AZD3355 and Nexium

Disease
gastroesophageal reflux disease
Drug Name
AZD3355
Generic Name
AZD3355
Sponsor
AstraZeneca
Drug Status
Discontinued
Phase
I
Start Date
Mar 27, 2008
Study Name
D9120C00016
Study Id
D9120C00016
ClinicalTrials.gov ID
NCT00684190
Recruiting Status
Closed
Protocol Status
Not Available
Report
Dec 4, 2008
  • D9120C00016.pdf (529 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013